RBM3 and neoplasm: A similarly reduced, borderline significant, PFS was demonstrated for tumours with intermediate RBM3 expression (Figure 3a), and when a dichotomised variable of high versus negative/intermediate RBM3 expression was applied, a significantly reduced PFS was seen for the latter category (p=0.048, Figure 3b).